Navigation Links
Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
Date:9/4/2007

PRESTON, England, Sept. 4 /PRNewswire-FirstCall/ -- Six hospitals in the north of England are implementing a Varian Medical Systems (NYSE: VAR) software system that enables them to function as one clinical network. The rollout of ARIA(TM) for Medical Oncology at hospitals in Lancashire and Cumbria is expected to improve patient care and departmental efficiency by fully integrating the prescribing, preparation, dispensing and administration of drugs for treating cancer.

The network will include oncology centers at the Royal Preston Hospital, Royal Blackburn Hospital, Burnley General Hospital, Blackpool Victoria Hospital, Royal Lancs Infirmary and Furness General Hospital will effectively have a single integrated computer network for chemotherapy prescribing and patient records.

Dr Gerry Skailes, the project's clinical director of oncology, says, "This will allow a seamless transition around the network and will enable patients to travel from one of our hospitals to another, as they tend to do if they are having both chemotherapy and radiotherapy. ARIA was selected because it ideally fitted our specifications and it is a well-established and trusted system.

"The result will be a more streamlined service which will enable us to provide better care for our patients while increasing our awareness of the treatments we are providing. It will make it a lot more convenient for all concerned."

Steve Laws, Varian's medical oncology sales manager, says, "ARIA for Medical Oncology provides cancer treatment facilities with software that combines and manages information including scheduling, prescribing and clinical information for both radiation therapy and chemotherapy within a single comprehensive electronic medical record for each patient."

Varian's medical oncology solution is already in place in several UK hospitals, including in London (St Barts), Norwich, Stoke, Truro and Romford, and is now being implemented across a number of other cancer networks.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068, neil.madle@varian.com

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,400 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. In Europe, the company operates manufacturing and engineering centers in Baden (Switzerland), Crawley (England), Haan (Germany), Helsinki (Finland) and Toulouse (France) and has headquarters for Europe, Middle East, India and Africa (EMEA) based in Zug, Switzerland. For more information, visit http://www.varian.com/.

Forward Looking Statements

Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "can" and "expect," constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks described in the company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Midwest shines among best hospitals in U.S.
2. Tech Digest: Inacom; St. Michaels, St. Clares hospitals; Merge eMed; Advanced Data-Comm; Blue Cross and Blue Shield
3. Digitizing hospitals with the right tools
4. GE Healthcare launches new medical scanner, places another in hospitals
5. TeraMedica offers system integration tool for hospitals
6. TDS Helps Florida Hospitals Implement High-Speed VPN
7. Avoid siRNA Design Altogether!
8. A (modern) Tale of Two Cities: Milwaukee and Madison inch together
9. Old bell system merging back together, but its not the same
10. The year of working together (really!)
11. Education conference to draw together games researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... , ... January 11, 2017 , ... ... Clinical Cancer Research show early promise of the investigational anti-cancer agent tucatinib (formerly ... median 5 previous treatment regimens. Twenty-seven percent of these heavily pretreated patients saw ...
(Date:1/11/2017)... ... January 11, 2017 , ... As ... in Peru studying the pathogens that cause malaria and tuberculosis. Seeing firsthand the ... of discovery. , Now, as an assistant professor of biology and biotechnology at ...
(Date:1/11/2017)... 2017  Brian Mehling, M.D., world-renowned stem cell researcher, ... International (BHI), will be attending the 47th Annual World ... from January 17-20, 2017. This will be Dr. Mehling,s ... theme of this year,s forum is Responsive and Responsible ... address strategies for fostering greater social inclusion and human ...
(Date:1/11/2017)... ... January 11, 2017 , ... While the most ... it is becoming increasingly clear that the evolution and transmission dynamics of resistance ... in the study of clinical resistance, has vastly underestimated these reservoirs of resistance ...
Breaking Biology Technology:
(Date:12/22/2016)... -- As part of its longstanding mission to improve genetic literacy ... released its latest children,s book, titled The One ... topics of inheritance and variation of traits that are part ... school classrooms in the US. The book ... Killoran , whose previous book with 23andMe, You ...
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL ... desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar ... 2017, con múltiples sitios previstos a lo largo de Europa y ... MSC-1 es ... inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ...
(Date:12/15/2016)... VANCOUVER, Canada and BADEN-BADEN, Germany ... Solutions, a leading global financial services provider, today announced an ... in passive behavioural biometrics, to join forces. The partnership will ... fraud mitigation strategies in compliance with local data protection regulation. ... In ...
Breaking Biology News(10 mins):